e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Dare Bioscience, Inc. - Common Stock
(NQ:
DARE
)
2.170
-0.010 (-0.46%)
Streaming Delayed Price
Updated: 10:33 AM EDT, Oct 6, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Dare Bioscience, Inc. - Common Stock
< Previous
1
2
3
4
Next >
This Brinker International Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
September 04, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 14, 2025
Via
Benzinga
Daré Bioscience Posts Narrower Q2 Loss
August 14, 2025
Via
The Motley Fool
Earnings Scheduled For August 14, 2025
August 14, 2025
Via
Benzinga
A Preview Of Dare Bioscience's Earnings
August 13, 2025
Via
Benzinga
Unusual volume stocks are being observed in Tuesday's session.
July 15, 2025
The trading volume of these stocks is deviating from the norm in today's session.
Via
Chartmill
Dare Bioscience's Earnings Outlook
May 12, 2025
Via
Benzinga
A Look Ahead: Dare Bioscience's Earnings Forecast
March 28, 2025
Via
Benzinga
US Stocks Close Mixed As Tariff Concerns Rise: Investor Sentiment Improves, Fear & Greed Index Remains In 'Extreme Greed' Zone
July 15, 2025
Via
Benzinga
These stocks are moving in today's session
July 14, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Crude Oil Moves Lower; Daré Bioscience Shares Jump
July 14, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
July 14, 2025
Via
Benzinga
Insights into Dare Bioscience's Upcoming Earnings
November 13, 2024
Via
Benzinga
Unusual volume stocks in Monday's session
July 14, 2025
Unusual volume stocks in Monday's session
Via
Chartmill
Which stocks are moving on Monday?
July 14, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
July 14, 2025
Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.
Via
Chartmill
US Stocks Edge Lower; Fastenal Posts Upbeat Earnings
July 14, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 14, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 04, 2025
Via
Benzinga
Earnings Scheduled For May 13, 2025
May 13, 2025
Via
Benzinga
Earnings Scheduled For March 31, 2025
March 31, 2025
Via
Benzinga
DARE Stock Earnings: Dare Bioscience Beats Revenue for Q2 2024
August 12, 2024
DARE stock results show that Dare Bioscience beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Earnings Scheduled For November 14, 2024
November 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
May 30, 2024
Via
Benzinga
Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 21, 2024
Via
Benzinga
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
May 17, 2024
Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe menopausal vasomotor symptoms compared to placebo.
Via
Benzinga
DARE Stock Earnings: Dare Bioscience Misses EPS, Beats Revenue for Q1 2024
May 14, 2024
DARE stock results show that Dare Bioscience missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 30, 2024
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Facebook
Twitter
YouTube